HIV protease inhibitors inhibit FACE1/ZMPSTE24: a mechanism for acquired lipodystrophy in patients on highly active antiretroviral therapy?

HIV protease inhibitors inhibit FACE1/ZMPSTE24: a mechanism for acquired lipodystrophy in patients on highly active antiretroviral therapy?

HIV-PIs (HIV protease inhibitors) have proved to be of great benefit for the millions of people suffering from AIDS. However, one of the side effects of this component of combined highly active antiretroviral therapy is lipodystrophy, which affects a large number of the patients taking this class of...

Descripció completa

Dades bibliogràfiques
Autors principals:	Goulbourne, C, Vaux, D
Format:	Journal article
Idioma:	English
Publicat:	Portland Press 2010

Ítems similars

The structural basis of ZMPSTE24-dependent laminopathies
per: Quigley, A, et al.
Publicat: (2013)

The structural basis of ZMPSTE24-dependent laminopathies.
per: Quigley, A, et al.
Publicat: (2013)

Prelamin A and ZMPSTE24 in premature and physiological aging
per: Howard J. Worman, et al.
Publicat: (2023-12-01)

ZMPSTE24 Is Associated with Elevated Inflammation and Progerin mRNA
per: Moritz Messner, et al.
Publicat: (2020-08-01)

Requirements for efficient proteolytic cleavage of prelamin A by ZMPSTE24.
per: Jemima Barrowman, et al.
Publicat: (2012-01-01)

Acquired and Inherited Lipodystrophies
Publicat: (2004-06-01)

Lipodystrophy in HIV/AIDS patients with different levels of physical activity while on antiretroviral therapy
per: Aline Francielle Mota Segatto, et al.
Publicat: (2011-08-01)

Lipodystrophy in Human Immunodeficiency Virus (HIV) Patients on Highly Active Antiretroviral Therapy (Haart)
per: N. Sunil Kumar, et al.
Publicat: (2015-07-01)

Inhibition of Arenavirus Entry and Replication by the Cell-Intrinsic Restriction Factor ZMPSTE24 Is Enhanced by IFITM Antiviral Activity
per: Robert J. Stott-Marshall, et al.
Publicat: (2022-02-01)

运用二代测序技术产前诊断ZMPSTE24基因突变
per: 麦明琴, et al.
Publicat: (2017-01-01)

The Senolytic Drug Fisetin Attenuates Bone Degeneration in the Zmpste24−/− Progeria Mouse Model
per: William S. Hambright, et al.
Publicat: (2023-01-01)

Case Report: Metreleptin and SGLT2 Inhibitor Combination Therapy Is Effective for Acquired Incomplete Lipodystrophy
per: Ayako Nagayama, et al.
Publicat: (2021-05-01)

Targeting CK2 eliminates senescent cells and prolongs lifespan in Zmpste24-deficient mice
per: Jie Zhang, et al.
Publicat: (2024-05-01)

HIV-1 protease as a target for antiretroviral therapy
per: Windsor, Ian William.
Publicat: (2019)

Acquired lipodystrophy following use of pembrolizumab
per: Maya Weitzen, et al.
Publicat: (2024-12-01)

Acquired partial lipodystrophy associated with varicella
per: Zafer Kurugöl, et al.
Publicat: (2009-12-01)

The Lipodystrophy Syndrome in HIV-Infected Children under Antiretroviral Therapy: A First Report from the Central Africa
per: Honoré Kalombayi Tshamala, et al.
Publicat: (2019-01-01)

Uridine metabolism in HIV-1-infected patients: effect of infection, of antiretroviral therapy and of HIV-1/ART-associated lipodystrophy syndrome.
per: Pere Domingo, et al.
Publicat: (2010-11-01)

Influence of the duration of antiretroviral use on insulin resistance among people living with HIV with lipodystrophy
per: Thiago Rodrigues Faria Vitorazzi, et al.
Publicat: (2018-12-01)

Defining substrate requirements for cleavage of farnesylated prelamin A by the integral membrane zinc metalloprotease ZMPSTE24.
per: Kaitlin M Wood, et al.
Publicat: (2020-01-01)

The farnesyl transferase inhibitor (FTI) lonafarnib improves nuclear morphology in ZMPSTE24-deficient fibroblasts from patients with the progeroid disorder MAD-B
per: Kamsi O. Odinammadu, et al.
Publicat: (2023-12-01)

Lipodystrophy syndrome in HIV /
per: Wanke, Christine A., et al.
Publicat: (2003)

The Place of protease inhibitors in antiretroviral treatment
per: S.B. Tenore, et al.

Prevalence of lipodystrophy and metabolic abnormalities in HIV-infected African children after 3 years on first-line antiretroviral therapy.
per: Bwakura-Dangarembizi, M, et al.
Publicat: (2015)

Mass spectrometry captures off-target drug binding and provides mechanistic insights into the human metalloprotease ZMPSTE24
per: Mehmood, S, et al.
Publicat: (2016)

ZMPSTE24 missense mutations that cause progeroid diseases decrease prelamin A cleavage activity and/or protein stability
per: Spear, ED, et al.
Publicat: (2018)

Accelerated aging in articular cartilage by ZMPSTE24 deficiency leads to osteoarthritis with impaired metabolic signaling and epigenetic regulation
per: Jinlong Suo, et al.
Publicat: (2023-05-01)

A Heterozygous ZMPSTE24 Mutation Associated with Severe Metabolic Syndrome, Ectopic Fat Accumulation, and Dilated Cardiomyopathy
per: Damien Galant, et al.
Publicat: (2016-04-01)

ZMPSTE24 missense mutations that cause progeroid diseases decrease prelamin A cleavage activity and/or protein stability
per: Eric D. Spear, et al.
Publicat: (2018-07-01)

Acquired HIV-1 Protease Conformational Flexibility Associated with Lopinavir Failure May Shape the Outcome of Darunavir Therapy after Antiretroviral Therapy Switch
per: Simeon Eche, et al.
Publicat: (2021-03-01)

Antiretroviral therapy outcomes in HIV-infected children after adjusting protease inhibitor dosing during tuberculosis treatment.
per: Cordula Frohoff, et al.
Publicat: (2011-02-01)

Anthropometric measurements and lipid profiles to detect early lipodystrophy in antiretroviral therapy experienced HIV-infected children in the CHAPAS-3 trial.
per: Musiime, V, et al.
Publicat: (2014)

Barraquer–Simons Lipodystrophy Syndrome in an Otherwise Normal Child: A Rare Case of Acquired Partial Lipodystrophy
per: Kananbala Sahu, et al.
Publicat: (2021-01-01)

A rare phenomenon of atypical lipodystrophy in a patient on HAART in the absence of a protease inhibitor regimen
per: Mohammed Mitha, et al.
Publicat: (2010-11-01)

Overview of HIV-related lipodystrophy
per: T Marie Rossouw, et al.
Publicat: (2013-02-01)

Hiv-associated lipodystrophy and exercise
per: E. Mutimura, et al.
Publicat: (2006-02-01)

Restrictive Dermopathy Due to ZMPSTE24 Mutation: A Case Report with a Novel Finding of Corpus Callosum Agenesis
per: Minu Jose Chiramel, et al.
Publicat: (2024-01-01)

Deficiency in ZMPSTE24 and resulting farnesyl–prelamin A accumulation only modestly affect mouse adipose tissue stores[S]
per: Patrick J. Heizer, et al.
Publicat: (2020-03-01)

Inherited and acquired lipodystrophies: molecular-genetic and autoimmune mechanisms
per: Ekaterina L. Sorkina, et al.
Publicat: (2018-04-01)

Acquired partial lipodystrophy: An atypical presentation with therapeutic challenge
per: Komali Garlapati, et al.
Publicat: (2015-01-01)